ENRICO GASPAR: Open Payments
NPI 1497740492 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 18 payments from 14 companies in 2025. Trend: 2023 $1,557 · 2024 $956 · 2025 $466
Food & beverage: $437Education: $29
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 1 | $99 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $49 |
| Novo Nordisk Inc | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
Products named: Zunveyl, REXULTI, Kerendia, UBRELVY, TRELEGY ELLIPTA, GEMTESA, The Cologuard Plus Collection Kit, Rybelsus.
Industry payments across AL — which companies pay providers there.
